Feature Story
Top News
-
Cardiol Therapeutics Submits Application for Uplisting to the Nasdaq and Raises Proceeds of Over $10 Million from Exercise of Warrants and Options
Tuesday, March 2, 2021 · Paul Archie
-
Big Pharma Dives Into CBD: Who Could Be Next?
Monday, February 22, 2021 · Paul Archie
-
Clinical Trials Focus on COVID-19 and Acute Myocarditis
Tuesday, January 19, 2021 · Paul Archie
-
Cardiol Therapeutics Announces Completion of Phase I Clinical Study of CardiolRx™
Tuesday, December 22, 2020 · Paul Archie
-
Cardiol Therapeutics Appoints Worldwide Clinical Trials as CRO for the Company’s Phase II/III Outcomes Trial in High-Risk Patients Hospitalized with COVID-19
Tuesday, December 15, 2020 · Paul Archie
Interviews
Features
News